Abstract
Circulating low-density lipoprotein (LDL) levels are a major risk factor for cardiovascular diseases (CVD), and even though current treatment strategies focusing on lowering lipid levels are effective, CVD remains the primary cause of death worldwide. Atherosclerosis is the major cause of CVD and is a chronic inflammatory condition in which various cell types and protein kinases play a crucial role. However, the underlying mechanisms of atherosclerosis are not entirely understood yet. Notably, protein kinases are highly druggable targets and represent, therefore, a novel way to target atherosclerosis. In this review, the potential role of the calcium/calmodulin-dependent protein kinase-like (CaMKL) family and its role in atherosclerosis will be discussed. This family consists of 12 subfamilies, among which are the well-described and conserved liver kinase B1 (LKB1) and 5 ' adenosine monophosphate-activated protein kinase (AMPK) subfamilies. Interestingly, LKB1 plays a key role and is considered a master kinase within the CaMKL family. It has been shown that LKB1 signaling leads to atheroprotective effects, while, for example, members of the microtubule affinity-regulating kinase (MARK) subfamily have been described to aggravate atherosclerosis development. These observations highlight the importance of studying kinases and their signaling pathways in atherosclerosis, bringing us a step closer to unraveling the underlying mechanisms of atherosclerosis.
Original language | English |
---|---|
Article number | 6213 |
Number of pages | 22 |
Journal | International Journal of Molecular Sciences |
Volume | 25 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Jun 2024 |
Externally published | Yes |
Keywords
- kinases
- CAMKL family
- atherosclerosis
- inflammation
- LOW-DENSITY-LIPOPROTEIN
- SMOOTH-MUSCLE-CELLS
- HUMAN ENDOTHELIAL-CELLS
- DNA-DAMAGE
- SELECTIVE RETENTION
- MYELOID DELETION
- ADIPOSE-TISSUE
- CHOLESTEROL
- ACTIVATION
- INHIBITION